Skip to main content
. 2021 Nov 3;34(4):365–371. doi: 10.1097/MEG.0000000000002299

Table 2.

Subgroup-sensitivity analyses on studies investigating the association between nonalcoholic fatty liver disease and incident hypertension

Hazard ratios (95% CI) Test for overall effect Study number Between group heterogeneity
Duration of follow-up
 <6 years 1.48 (1.16–1.89) z = 3.182, P = 0.001 7 P = 0.176
 ≥6 years 2.10 (1.35–3.20) z = 3.325, P = 0.001 4
Adjustment for baseline BP
 Absent 1.78 (1.16–2.73) z = 2.647, P = 0.008 5 P = 0.655
 Present 1.60 (1.33–1.93) z = 4.881, P < 0.001 6
Adjustment for adipositya
 Absent 2.44 (1.84–3.22) z = 6.229, P < 0.001 4 P < 0.001
 Present 1.36 (1.20–1.54) z = 4.871, P < 0.001 7
Geographical region
 Europe/USA 1.97 (1.23–3.15) z = 2.830, P = 0.005 3 P = 0.401
 Asia 1.58 (1.27–1.96) z = 4.078, P < 0.001 8

All studies included in Fig. 2 were analyzed in these subgroup analyses.

a

Inclusion of either BMI or waist circumference in the multivariable logistic regression model.

BP, blood pressure; CI, confidence interval.